[由于可能的华法林/奥塞尔塔米维尔药物相互作用引起的胃肠道出血:病例报告]
Jonathan Abisror1, Roya Asgari2, Quentin de Baynast3
1Service de pharmacie à usage intérieur, hôpital européen Georges-Pompidou, Assistance publique-Hôpitaux de Paris, 20, rue Leblanc, 75015 Paris, France.
概括
华法林和奥塞塔米维尔的相互作用可能会导致严重出血. 密切监测国际规范化比率 (INR) 是至关重要的,特别是在患有功能衰竭的患者,在治疗中.
科学领域:
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
- 临床药房 临床药房
背景情况:
- 像华法林这样的维生素K抗剂疗法,存在因出血而导致阳性住院的风险.
- 华法林和奥塞尔塔米维尔之间的药物相互作用很少被报告,但可能导致严重的出血并发症.
研究的目的:
- 报告华法林和oseltamivir之间显著药物相互作用的病例.
- 要强调监测接受两种药物的患者国际正常化比率 (INR) 的重要性.
主要方法:
- 一个64岁的妇女在华法林治疗中使用机械心脏门假肢的案例报告.
- 在中度功能不全的患者中,引入治疗流感的oseltamivir.
- 监测国际规范化比率 (INR) 和消化道出血的管理.
主要成果:
- 奥赛塔米维尔治疗导致INR在一周内迅速增加.
- 患者因华法林过量服用而再次出现消化道出血.
- 用维生素K和前素复合度进行症状管理,纠正了INR过量.
结论:
- 在接受华法林治疗的患者中引入奥塞尔塔米维尔需要密切的INR监测.
- 监测应该发生从oseltamivir开始,直到其完全消除 (3天后停止).
- 功能衰竭是增加这种药物相互作用风险的关键因素.
相关概念视频
Venous Thrombosis IV: Nursing Management
192
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
192
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.1K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
198
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
198
Venous Thrombosis III: Interprofessional Care
276
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
276
Esophageal Varices-II: Clinical Features and Management
359
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
359
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K

